Andrew Churchyard

4.7k total citations
89 papers, 2.8k citations indexed

About

Andrew Churchyard is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Andrew Churchyard has authored 89 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Cellular and Molecular Neuroscience, 61 papers in Neurology and 29 papers in Molecular Biology. Recurrent topics in Andrew Churchyard's work include Genetic Neurodegenerative Diseases (70 papers), Neurological disorders and treatments (46 papers) and Mitochondrial Function and Pathology (23 papers). Andrew Churchyard is often cited by papers focused on Genetic Neurodegenerative Diseases (70 papers), Neurological disorders and treatments (46 papers) and Mitochondrial Function and Pathology (23 papers). Andrew Churchyard collaborates with scholars based in Australia, United Kingdom and United States. Andrew Churchyard's co-authors include Nellie Georgiou‐Karistianis, Phyllis Chua, Julie C. Stout, Gary F. Egan, Govinda Poudel, Juan F. Domínguez D, Louise A. Corben, Martin B. Delatycki, John L. Bradshaw and Michael Fahey and has published in prestigious journals such as PLoS ONE, Brain and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Andrew Churchyard

87 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Churchyard Australia 33 1.9k 1.8k 978 389 304 89 2.8k
Louise A. Corben Australia 31 1.9k 1.0× 1.1k 0.6× 1.5k 1.5× 378 1.0× 184 0.6× 132 2.9k
Robert J. Ferrante United States 12 1.8k 0.9× 899 0.5× 1.4k 1.4× 466 1.2× 315 1.0× 16 2.9k
Michael Abele Germany 25 1.5k 0.8× 1.5k 0.9× 903 0.9× 188 0.5× 229 0.8× 57 2.4k
Véronique Sgambato France 27 1.4k 0.7× 1.4k 0.8× 648 0.7× 493 1.3× 111 0.4× 53 2.7k
F. Girotti Italy 32 1.2k 0.6× 2.1k 1.2× 497 0.5× 470 1.2× 180 0.6× 114 2.9k
Julian Fearnley United Kingdom 11 1.4k 0.7× 2.6k 1.5× 493 0.5× 324 0.8× 233 0.8× 11 3.3k
Norbert Brüggemann Germany 31 1.1k 0.6× 2.1k 1.2× 802 0.8× 406 1.0× 107 0.4× 192 3.3k
Beth Borowsky United States 17 2.3k 1.2× 1.8k 1.0× 1.2k 1.3× 298 0.8× 211 0.7× 35 2.7k
Paola Soliveri Italy 33 977 0.5× 1.9k 1.1× 495 0.5× 487 1.3× 133 0.4× 80 2.8k
Jean‐Philippe Azulay France 31 858 0.4× 2.0k 1.1× 317 0.3× 437 1.1× 170 0.6× 107 2.8k

Countries citing papers authored by Andrew Churchyard

Since Specialization
Citations

This map shows the geographic impact of Andrew Churchyard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Churchyard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Churchyard more than expected).

Fields of papers citing papers by Andrew Churchyard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Churchyard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Churchyard. The network helps show where Andrew Churchyard may publish in the future.

Co-authorship network of co-authors of Andrew Churchyard

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Churchyard. A scholar is included among the top collaborators of Andrew Churchyard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Churchyard. Andrew Churchyard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cummins, Tarrant D.R., et al.. (2016). Cortical inhibitory deficits in Huntington's disease are not influenced by gender. Psychiatry Research Neuroimaging. 257. 1–4. 4 indexed citations
2.
Delatycki, Martin B., Andrew Churchyard, Eppie M. Yiu, et al.. (2016). Autosomal dominant lower limb restricted congenital myopathy. Neuromuscular Disorders. 26. S116–S116. 1 indexed citations
3.
Cummins, Tarrant D.R., et al.. (2015). Cortical inhibitory deficits in premanifest and early Huntington’s disease. Behavioural Brain Research. 296. 311–317. 27 indexed citations
4.
Fisher, Caroline A., et al.. (2014). Aggression in Huntington's Disease: A Systematic Review of Rates of Aggression and Treatment Methods. Journal of Huntington s Disease. 3(4). 319–332. 43 indexed citations
5.
Tai, Geneieve, Louise A. Corben, Lyle C. Gurrin, et al.. (2014). A study of up to 12 years of follow-up of Friedreich ataxia utilising four measurement tools. Journal of Neurology Neurosurgery & Psychiatry. 86(6). 660–666. 17 indexed citations
6.
Yiu, Eppie M., Geneieve Tai, Roger E. Peverill, et al.. (2013). An Open Label Clinical Pilot Study of Resveratrol as a Treatment for Friedreich Ataxia (S43.006). Neurology. 80(7_supplement). 2 indexed citations
7.
D, Juan F. Domínguez, Gary F. Egan, Marcus A. Gray, et al.. (2013). Multi-Modal Neuroimaging in Premanifest and Early Huntington’s Disease: 18 Month Longitudinal Data from the IMAGE-HD Study. PLoS ONE. 8(9). e74131–e74131. 74 indexed citations
8.
Georgiou‐Karistianis, Nellie, Julie C. Stout, Juan F. Domínguez D, et al.. (2013). Functional magnetic resonance imaging of working memory in Huntington's disease: Cross‐sectional data from the IMAGE‐HD study. Human Brain Mapping. 35(5). 1847–1864. 55 indexed citations
9.
Andrews, Sophie C., et al.. (2012). Home or Residential Care? The Role of Behavioral and Psychosocial Factors in Determining Discharge Outcomes for Inpatients with Huntington's Disease. Journal of Huntington s Disease. 1(2). 187–193. 8 indexed citations
10.
Georgiou‐Karistianis, Nellie, Maree Farrow, Michelle Wilson‐Ching, et al.. (2012). Deficits in Selective Attention in Symptomatic Huntington Disease. Cognitive and Behavioral Neurology. 25(1). 1–6. 8 indexed citations
11.
Sritharan, Anusha, Gary F. Egan, Leigh A. Johnston, et al.. (2009). A longitudinal diffusion tensor imaging study in symptomatic Huntington's disease. Journal of Neurology Neurosurgery & Psychiatry. 81(3). 257–262. 56 indexed citations
12.
Corben, Louise A., Martin B. Delatycki, John L. Bradshaw, et al.. (2009). Impairment in motor reprogramming in Friedreich ataxia reflecting possible cerebellar dysfunction. Journal of Neurology. 257(5). 782–791. 30 indexed citations
13.
Fahey, Michael, Phillip D. Cremer, S. T. Aw, et al.. (2008). Vestibular, saccadic and fixation abnormalities in genetically confirmed Friedreich ataxia. Brain. 131(4). 1035–1045. 102 indexed citations
14.
Wilcox, Robert A., et al.. (2007). Levodopa response in Parkinsonism with multiple mitochondrial DNA deletions. Movement Disorders. 22(7). 1020–1023. 10 indexed citations
15.
Loesch, Danuta Z., L. Litewka, Andrew Churchyard, et al.. (2006). Tremor/ataxia syndrome and fragile X premutation: Diagnostic caveats. Journal of Clinical Neuroscience. 14(3). 245–248. 17 indexed citations
16.
Loesch, Danuta Z., et al.. (2005). Evidence for, and a spectrum of, neurological involvement in carriers of the fragile X pre‐mutation: FXTAS and beyond. Clinical Genetics. 67(5). 412–417. 61 indexed citations
17.
Churchyard, Andrew, et al.. (1998). Panniculitis in association with apomorphine infusion.. UCL Discovery (University College London). 15 indexed citations
18.
19.
Morris, Meg E., Robert Iansek, & Andrew Churchyard. (1998). The role of the physiotherapist in quantifying movement fluctuations in Parkinson's disease. Australian Journal of Physiotherapy. 44(2). 105–114. 18 indexed citations
20.
Morris, Meg E., Andrew Churchyard, & Robert Iansek. (1998). How to conduct a dose response trial of Parkinson's disease medication. Australian Journal of Physiotherapy. 44(2). 131–133. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louise A. Corben Breakdown of academic impact, for papers by Robert J. Ferrante Breakdown of academic impact, for papers by Michael Abele Breakdown of academic impact, for papers by Véronique Sgambato Breakdown of academic impact, for papers by F. Girotti Breakdown of academic impact, for papers by Julian Fearnley Breakdown of academic impact, for papers by Norbert Brüggemann Breakdown of academic impact, for papers by Beth Borowsky Breakdown of academic impact, for papers by Paola Soliveri Breakdown of academic impact, for papers by Jean‐Philippe Azulay
Rankless by CCL
2026